Your session is about to expire
← Back to Search
eBook + CHOICES Intervention for Sickle Cell Disease (CHOICES3 Trial)
CHOICES3 Trial Summary
This trial will test whether nudges and tailored boosters can help people with sickle cell disease or thalassemia have a child free of their condition.
CHOICES3 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCHOICES3 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CHOICES3 Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am at risk of having a child with sickle cell disease.I am between 18 and 45 years old.I plan to try for a baby within the next 2 years.I want to prevent having a child with sickle cell disease.I am unable to fill out study forms or participate in the study activities.I have been diagnosed with sickle cell disease or carry the sickle cell trait.I am legally blind.I do not wish to have children in the future.I know someone or have myself been part of this or a related study before.
- Group 1: CHOICES
- Group 2: eBook (electronic-Book)
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are participants being recruited presently for this research initiative?
"According to information available on clinicaltrials.gov, this particular medical study is open for recruitment and has been since June 1st 2022. The trial was recently updated on May 31st of the same year."
Is this investigation open to persons of an advanced age?
"This experiment has a strict age limit of 18 to 35, with separate trials being conducted for those under 18 and over 65. Consequently, 132 studies are running for minors while 88 cater to the elderly population."
May I be included in this medical experiment?
"This clinical trial requires all applicants to have the sickle cell trait, and they must be aged between 18-35. Currently, this medical study is seeking out a total of 506 individuals for participation."
What is the sample size of the participants in this clinical trial?
"Absolutely, according to the information found on clinicaltrials.gov, this medical trial is currently enrolling patients from a single site. The study was first advertised on June 1st 2022 and has been updated as recently as May 31st 2022; 506 people are needed for participation in total."
Share this study with friends
Copy Link
Messenger